Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and/or 2(HDAC1-2)

Heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and/or 2(HDAC1-2)

US Patent 11241428 · Granted Feb 8, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cocrystals of (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane2025
N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE2) receptors mod2024
N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE2) receptors mod2024
Androgen receptor and glucocorticoid receptor modulators2022
Benzamide derivatives as PPAR-gamma modulators2022
Benzamide derivatives as PPAR-gamma modulators2022
Benzamide derivatives as PPAR-gamma modulators2022
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use th2021
Pyridoquinazoline derivatives useful as protein kinase inhibitors2021
Adenosine A3 receptor modulators2020
Adenosine A3 receptor modulators2020
Amine salt of (1R, 3S)-3-(5-cyano-4-phenyl-1,3- thiazol-2-ylcarbamoyl)cyclopenta2020